Trial intelligence / Profile preview

Real-world study of nab-paclitaxel for gastric cancer in Anhui Province

ChiCTR1800020429Phase 4Recruiting

Sponsor
First Affiliated Hospital of Anhui Medical University
Start
Dec 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of paclitaxel in gastric cancer (GC), sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoints: progression-free survival and disease-free survival. Started Dec 2018; status: recruiting.

02

Drugs

paclitaxel
03

Conditions

gastric cancer (GC)

Beyond the preview

Go deeper on ChiCTR1800020429.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1800020429.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call